Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDApplied Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | -$0.39 | $0.01 | -$0.16 |
| Q2 2024 | 1 | -$0.40 | $0.01 | -$0.16 |
| Q3 2024 | 1 | -$0.38 | $0.01 | -$0.16 |
| Q4 2024 | 3 | -$0.23 | -$0.16 | -$0.20 |
| Q1 2025 | 2 | -$0.13 | -$0.12 | -$0.12 |
| Q2 2025 | 1 | -$0.42 | $0.01 | -$0.17 |
| Q3 2025 | 1 | -$0.39 | $0.01 | -$0.16 |
| Q4 2025 | 1 | -$0.36 | $0.01 | -$0.15 |
| Q1 2026 | 1 | -$0.35 | $0.01 | -$0.14 |
| Q2 2026 | 1 | -$0.25 | $0.00 | -$0.10 |
| Q3 2026 | 1 | -$0.14 | $0.00 | -$0.06 |
| Q4 2026 | 1 | -$0.04 | $0.00 | -$0.02 |
Applied Therapeutics, Inc. Earnings Date And Information
Applied Therapeutics, Inc. last posted its earnings results on Thursday, November 7th, 2024. The company reported $-0.2 earnings per share for the quarter, missing analysts' consensus estimates of $-0.13 by $0.07. The company had revenue of 122,000 for the quarter and had revenue of 9.99 M for the year. Applied Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-1.42 diluted earnings per share) and currently has a price-to-earnings ratio of -0.07. Applied Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based on prior year's report dates.
Applied Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/07/2024 | Q3 2024 | -$0.13 | -$4.75 | -4.62 | $75,000 | $122,000 |
| 08/07/2024 | Q2 2024 | -$0.10 | $0.06 | 0.16 | $2.50 M | $144,000 |
| 05/09/2024 | Q1 2024 | -$0.07 | -$1.70 | -1.63 | $190,000 | |
| 03/06/2024 | Q4 2023 | -$0.15 | -$0.45 | -0.3 | $-667,000 | |
| 11/09/2023 | Q3 2023 | -$0.26 | -$0.47 | -0.21 | $8.00 M | $0 |
| 08/10/2023 | Q2 2023 | -$0.26 | -$0.37 | -0.11 | $20.00 M | $0 |
| 05/11/2023 | Q1 2023 | -$0.31 | -$0.17 | 0.14 | $10.66 M | |
| 03/23/2023 | Q4 2022 | $0.46 | -$0.12 | -0.58 | $0 | |
| 11/09/2022 | Q3 2022 | -$0.45 | -$0.39 | 0.06 | $0 | |
| 08/12/2022 | Q2 2022 | -$0.78 | -$1.28 | -0.5 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.82 | -$0.88 | -0.06 | $0 | |
| 03/10/2022 | Q4 2021 | -$1.22 | -$1.05 | 0.17 | $0 | |
| 11/12/2021 | Q3 2021 | -$0.99 | -$1.09 | -0.1 | $0 | |
| 08/12/2021 | Q2 2021 | -$0.99 | -$0.99 | 0 | $0 | |
| 05/11/2021 | Q1 2021 | -$1.06 | -$1.00 | 0.06 | $0 | |
| 03/18/2021 | Q4 2020 | -$1.31 | -$0.98 | 0.33 | $0 | |
| 11/12/2020 | Q3 2020 | -$1.04 | -$1.33 | -0.29 | $0 | |
| 08/11/2020 | Q2 2020 | -$0.72 | -$1.27 | -0.55 | $0 | |
| 05/11/2020 | Q1 2020 | -$0.75 | -$0.59 | 0.16 | $0 | |
| 03/13/2020 | Q4 2019 | -$0.63 | -$0.85 | -0.22 | $0 |
Applied Therapeutics, Inc. Earnings: FAQ's
When is Applied Therapeutics, Inc.'s earnings date?
Applied Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 4th, 2025 based off last year's report dates.
How can I listen to Applied Therapeutics, Inc.'s earnings conference
call?
The conference call for Applied Therapeutics, Inc.'s latest earnings report can be listened to online.
How can I read Applied Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Applied Therapeutics, Inc.'s latest earnings report can be read online.
How much revenue does Applied Therapeutics, Inc. generate each year?
Applied Therapeutics, Inc. (:APLT) has a recorded annual revenue of $9.99 M.
How much profit does Applied Therapeutics, Inc. generate each year?
Applied Therapeutics, Inc. (:APLT) has a recorded net income of $9.99 M. Applied Therapeutics, Inc. has generated $-1.42 earnings per share over the last four quarters.
What is Applied Therapeutics, Inc.'s price-to-earnings ratio?
Applied Therapeutics, Inc. (:APLT) has a price-to-earnings ratio of -0.07 and price/earnings-to-growth ratio is 0.